Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 34 entries
Sorted by: Best Match Show Resources per page
[Charles Gouygou (1919-1977)].

La Nouvelle presse medicale

Duperrat B.
PMID: 341076
Nouv Presse Med. 1977 Nov 05;6(37):3453.

No abstract available.

Cite
Duperrat B. Charles Gouygou (1919-1977). [Charles Gouygou (1919-1977)]. Nouv Presse Med. 1977;6(37):3453
Duperrat, B. (1977). Charles Gouygou (1919-1977). [Charles Gouygou (1919-1977)]. La Nouvelle presse medicale, 6(37), 3453.
Duperrat, B. "Charles Gouygou (1919-1977)." [Charles Gouygou (1919-1977)]. La Nouvelle presse medicale vol. 6,37 (1977): 3453.
Duperrat B. Charles Gouygou (1919-1977). [Charles Gouygou (1919-1977)]. Nouv Presse Med. 1977 Nov 05;6(37):3453. French. PMID: 341076.
Copy Download .nbib Format: NLM
Optimization of ultrathin-film nonresonant Raman spectra provided by combining a light-trapping device, a high N.A. objective, and a spectrometer.

Applied optics

Aurengo A, Levy Y, Dupeyrat R.
PMID: 18195834
Appl Opt. 1983 Feb 15;22(4):602-8. doi: 10.1364/ao.22.000602.

The association of a four-media stratified illumination device and a high N.A. objective allowed us to obtain nonresonant Raman spectra of ultrathin films. The signal-to-noise ratio provided by this combination was computed. From this ratio we derived the optimization...

Cite
Aurengo A, Levy Y, Dupeyrat R. Optimization of ultrathin-film nonresonant Raman spectra provided by combining a light-trapping device, a high N.A. objective, and a spectrometer. Appl Opt. 1983;22(4):602-8doi: 10.1364/ao.22.000602.
Aurengo, A., Levy, Y., & Dupeyrat, R. (1983). Optimization of ultrathin-film nonresonant Raman spectra provided by combining a light-trapping device, a high N.A. objective, and a spectrometer. Applied optics, 22(4), 602-8. https://doi.org/10.1364/ao.22.000602
Aurengo, A, et al. "Optimization of ultrathin-film nonresonant Raman spectra provided by combining a light-trapping device, a high N.A. objective, and a spectrometer." Applied optics vol. 22,4 (1983): 602-8. doi: https://doi.org/10.1364/ao.22.000602
Aurengo A, Levy Y, Dupeyrat R. Optimization of ultrathin-film nonresonant Raman spectra provided by combining a light-trapping device, a high N.A. objective, and a spectrometer. Appl Opt. 1983 Feb 15;22(4):602-8. doi: 10.1364/ao.22.000602. PMID: 18195834.
Copy Download .nbib Format: NLM
Terbium(III) Luminescent Complexes as Millisecond-Scale Viscosity Probes for Lifetime Imaging.

Journal of the American Chemical Society

Bui AT, Grichine A, Duperray A, Lidon P, Riobé F, Andraud C, Maury O.
PMID: 28551987
J Am Chem Soc. 2017 Jun 14;139(23):7693-7696. doi: 10.1021/jacs.7b02951. Epub 2017 May 31.

Fluorescent probes that are able to directly measure viscosity are attractive candidates for the study of intracellular environments. We report a new class of luminescent rotors, based on the sensitized emission of a terbium(III) complex. A 4-fold increase in...

Cite
Bui AT, Grichine A, Duperray A, et al. Terbium(III) Luminescent Complexes as Millisecond-Scale Viscosity Probes for Lifetime Imaging. J Am Chem Soc. 2017;139(23):7693-7696doi: 10.1021/jacs.7b02951.
Bui, A. T., Grichine, A., Duperray, A., Lidon, P., Riobé, F., Andraud, C., & Maury, O. (2017). Terbium(III) Luminescent Complexes as Millisecond-Scale Viscosity Probes for Lifetime Imaging. Journal of the American Chemical Society, 139(23), 7693-7696. https://doi.org/10.1021/jacs.7b02951
Bui, Anh Thy, et al. "Terbium(III) Luminescent Complexes as Millisecond-Scale Viscosity Probes for Lifetime Imaging." Journal of the American Chemical Society vol. 139,23 (2017): 7693-7696. doi: https://doi.org/10.1021/jacs.7b02951
Bui AT, Grichine A, Duperray A, Lidon P, Riobé F, Andraud C, Maury O. Terbium(III) Luminescent Complexes as Millisecond-Scale Viscosity Probes for Lifetime Imaging. J Am Chem Soc. 2017 Jun 14;139(23):7693-7696. doi: 10.1021/jacs.7b02951. Epub 2017 May 31. PMID: 28551987.
Copy Download .nbib Format: NLM
Twisted Charge-Transfer Antennae for Ultra-Bright Terbium(III) and Dysprosium(III) Bioprobes.

Chemistry (Weinheim an der Bergstrasse, Germany)

Bui AT, Roux A, Grichine A, Duperray A, Andraud C, Maury O.
PMID: 29341302
Chemistry. 2018 Mar 07;24(14):3408-3412. doi: 10.1002/chem.201705933. Epub 2018 Feb 05.

The design of original twisted charge transfer antennae in which a non-planar geometry is enforced thanks to one or two bulky ortho-Me substituents allows us to prepare the corresponding ultra-bright Tb

Cite
Bui AT, Roux A, Grichine A, et al. Twisted Charge-Transfer Antennae for Ultra-Bright Terbium(III) and Dysprosium(III) Bioprobes. Chemistry. 2018;24(14):3408-3412doi: 10.1002/chem.201705933.
Bui, A. T., Roux, A., Grichine, A., Duperray, A., Andraud, C., & Maury, O. (2018). Twisted Charge-Transfer Antennae for Ultra-Bright Terbium(III) and Dysprosium(III) Bioprobes. Chemistry (Weinheim an der Bergstrasse, Germany), 24(14), 3408-3412. https://doi.org/10.1002/chem.201705933
Bui, Anh Thy, et al. "Twisted Charge-Transfer Antennae for Ultra-Bright Terbium(III) and Dysprosium(III) Bioprobes." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 24,14 (2018): 3408-3412. doi: https://doi.org/10.1002/chem.201705933
Bui AT, Roux A, Grichine A, Duperray A, Andraud C, Maury O. Twisted Charge-Transfer Antennae for Ultra-Bright Terbium(III) and Dysprosium(III) Bioprobes. Chemistry. 2018 Mar 07;24(14):3408-3412. doi: 10.1002/chem.201705933. Epub 2018 Feb 05. PMID: 29341302.
Copy Download .nbib Format: NLM
Paroxysmal Permeability Disorders: Development of a Microfluidic Device to Assess Endothelial Barrier Function.

Frontiers in medicine

Wu MA, Tsvirkun D, Bureau L, Boccon-Gibod I, Inglebert M, Duperray A, Bouillet L, Misbah C, Cicardi M.
PMID: 31069229
Front Med (Lausanne). 2019 Apr 24;6:89. doi: 10.3389/fmed.2019.00089. eCollection 2019.

No abstract available.

Cite
Wu MA, Tsvirkun D, Bureau L, et al. Paroxysmal Permeability Disorders: Development of a Microfluidic Device to Assess Endothelial Barrier Function. Front Med (Lausanne). 2019;6:89doi: 10.3389/fmed.2019.00089.
Wu, M. A., Tsvirkun, D., Bureau, L., Boccon-Gibod, I., Inglebert, M., Duperray, A., Bouillet, L., Misbah, C., & Cicardi, M. (2019). Paroxysmal Permeability Disorders: Development of a Microfluidic Device to Assess Endothelial Barrier Function. Frontiers in medicine, 689. https://doi.org/10.3389/fmed.2019.00089
Wu, Maddalena Alessandra, et al. "Paroxysmal Permeability Disorders: Development of a Microfluidic Device to Assess Endothelial Barrier Function." Frontiers in medicine vol. 6 (2019): 89. doi: https://doi.org/10.3389/fmed.2019.00089
Wu MA, Tsvirkun D, Bureau L, Boccon-Gibod I, Inglebert M, Duperray A, Bouillet L, Misbah C, Cicardi M. Paroxysmal Permeability Disorders: Development of a Microfluidic Device to Assess Endothelial Barrier Function. Front Med (Lausanne). 2019 Apr 24;6:89. doi: 10.3389/fmed.2019.00089. eCollection 2019. PMID: 31069229; PMCID: PMC6491734.
Copy Download .nbib Format: NLM
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor.

Journal for immunotherapy of cancer

You D, Hillerman S, Locke G, Chaudhry C, Stromko C, Murtaza A, Fan Y, Koenitzer J, Chen Y, Briceno S, Bhadra R, Duperret E, Gullo-Brown J, Gao C, Zhao D, Feder J, Curtin J, Degnan AP, Kumi G, Wittman M, Johnson BM, Parrish KE, Gokulrangan G, Morrison J, Quigley M, Hunt JT, Salter-Cid L, Lees E, Sanjuan MA, Liu J.
PMID: 33408094
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001402.

BACKGROUND: Hematopoietic progenitor kinase 1 (HPK1 or MAP4K1) has been demonstrated as a negative intracellular immune checkpoint in mediating antitumor immunity in studies with HPK1 knockout and kinase dead mice. Pharmacological inhibition of HPK1 is desirable to investigate the...

Cite
You D, Hillerman S, Locke G, et al. Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor. J Immunother Cancer. 2021;9(1)doi: 10.1136/jitc-2020-001402.
You, D., Hillerman, S., Locke, G., Chaudhry, C., Stromko, C., Murtaza, A., Fan, Y., Koenitzer, J., Chen, Y., Briceno, S., Bhadra, R., Duperret, E., Gullo-Brown, J., Gao, C., Zhao, D., Feder, J., Curtin, J., Degnan, A. P., Kumi, G., Wittman, M., Johnson, B. M., Parrish, K. E., Gokulrangan, G., Morrison, J., Quigley, M., Hunt, J. T., Salter-Cid, L., Lees, E., Sanjuan, M. A., & Liu, J. (2021). Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor. Journal for immunotherapy of cancer, 9(1), . https://doi.org/10.1136/jitc-2020-001402
You, Dan, et al. "Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor." Journal for immunotherapy of cancer vol. 9,1 (2021). doi: https://doi.org/10.1136/jitc-2020-001402
You D, Hillerman S, Locke G, Chaudhry C, Stromko C, Murtaza A, Fan Y, Koenitzer J, Chen Y, Briceno S, Bhadra R, Duperret E, Gullo-Brown J, Gao C, Zhao D, Feder J, Curtin J, Degnan AP, Kumi G, Wittman M, Johnson BM, Parrish KE, Gokulrangan G, Morrison J, Quigley M, Hunt JT, Salter-Cid L, Lees E, Sanjuan MA, Liu J. Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor. J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001402. PMID: 33408094; PMCID: PMC7789447.
Copy Download .nbib Format: NLM
A "Multi-Heavy-Atom" Approach toward Biphotonic Photosensitizers with Improved Singlet-Oxygen Generation Properties.

Chemistry (Weinheim an der Bergstrasse, Germany)

Galland M, Le Bahers T, Banyasz A, Lascoux N, Duperray A, Grichine A, Tripier R, Guyot Y, Maynadier M, Nguyen C, Gary-Bobo M, Andraud C, Monnereau C, Maury O.
PMID: 30972809
Chemistry. 2019 Jul 05;25(38):9026-9034. doi: 10.1002/chem.201901047. Epub 2019 May 30.

Two trispicolinate 1,4,7-triazacyclonane (TACN)-based ligands bearing three picolinate biphotonic antennae were synthetized and their Yb

Cite
Galland M, Le Bahers T, Banyasz A, et al. A "Multi-Heavy-Atom" Approach toward Biphotonic Photosensitizers with Improved Singlet-Oxygen Generation Properties. Chemistry. 2019;25(38):9026-9034doi: 10.1002/chem.201901047.
Galland, M., Le Bahers, T., Banyasz, A., Lascoux, N., Duperray, A., Grichine, A., Tripier, R., Guyot, Y., Maynadier, M., Nguyen, C., Gary-Bobo, M., Andraud, C., Monnereau, C., & Maury, O. (2019). A "Multi-Heavy-Atom" Approach toward Biphotonic Photosensitizers with Improved Singlet-Oxygen Generation Properties. Chemistry (Weinheim an der Bergstrasse, Germany), 25(38), 9026-9034. https://doi.org/10.1002/chem.201901047
Galland, Margaux, et al. "A "Multi-Heavy-Atom" Approach toward Biphotonic Photosensitizers with Improved Singlet-Oxygen Generation Properties." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 25,38 (2019): 9026-9034. doi: https://doi.org/10.1002/chem.201901047
Galland M, Le Bahers T, Banyasz A, Lascoux N, Duperray A, Grichine A, Tripier R, Guyot Y, Maynadier M, Nguyen C, Gary-Bobo M, Andraud C, Monnereau C, Maury O. A "Multi-Heavy-Atom" Approach toward Biphotonic Photosensitizers with Improved Singlet-Oxygen Generation Properties. Chemistry. 2019 Jul 05;25(38):9026-9034. doi: 10.1002/chem.201901047. Epub 2019 May 30. PMID: 30972809.
Copy Download .nbib Format: NLM
Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors.

PloS one

Vigouroux A, Garret C, Lascarrou JB, Martin M, Miailhe AF, Lemarié J, Dupeyrat J, Zambon O, Seguin A, Reignier J, Canet E.
PMID: 34928984
PLoS One. 2021 Dec 20;16(12):e0261443. doi: 10.1371/journal.pone.0261443. eCollection 2021.

BACKGROUND: Alcohol withdrawal syndrome (AWS) is a common condition in hospitalized patients, yet its epidemiology in the ICU remains poorly characterized.METHODS: Retrospective cohort of patients admitted to the Nantes University Hospital ICU between January 1, 2017, and December 31,...

Cite
Vigouroux A, Garret C, Lascarrou JB, et al. Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors. PLoS One. 2021;16(12):e0261443doi: 10.1371/journal.pone.0261443.
Vigouroux, A., Garret, C., Lascarrou, J. B., Martin, M., Miailhe, A. F., Lemarié, J., Dupeyrat, J., Zambon, O., Seguin, A., Reignier, J., & Canet, E. (2021). Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors. PloS one, 16(12), e0261443. https://doi.org/10.1371/journal.pone.0261443
Vigouroux, Aliénor, et al. "Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors." PloS one vol. 16,12 (2021): e0261443. doi: https://doi.org/10.1371/journal.pone.0261443
Vigouroux A, Garret C, Lascarrou JB, Martin M, Miailhe AF, Lemarié J, Dupeyrat J, Zambon O, Seguin A, Reignier J, Canet E. Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors. PLoS One. 2021 Dec 20;16(12):e0261443. doi: 10.1371/journal.pone.0261443. eCollection 2021. PMID: 34928984.
Copy Download .nbib Format: NLM
Extracorporeal Cardiopulmonary Resuscitation and Survival After Refractory Cardiac Arrest: Is ECPR Beneficial?.

ASAIO journal (American Society for Artificial Internal Organs : 1992)

Daubin C, Brunet J, Huet J, Valette X, Charbonnier C, Sabatier R, Joret A, Dupeyrat J, Saplacan V, Courtois S, Goursaud S, Fischer MO, Babatasi G, Morello R, Du Cheyron D.
PMID: 34734925
ASAIO J. 2021 Nov 01;67(11):1232-1239. doi: 10.1097/MAT.0000000000001391.

The level of evidence of expert recommendations for starting extracorporeal cardiopulmonary resuscitation (ECPR) in refractory out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) is low. Therefore, we reported our experience in the field to identify factors associated with...

Cite
Daubin C, Brunet J, Huet J, et al. Extracorporeal Cardiopulmonary Resuscitation and Survival After Refractory Cardiac Arrest: Is ECPR Beneficial?. ASAIO J. 2021;67(11):1232-1239doi: 10.1097/MAT.0000000000001391.
Daubin, C., Brunet, J., Huet, J., Valette, X., Charbonnier, C., Sabatier, R., Joret, A., Dupeyrat, J., Saplacan, V., Courtois, S., Goursaud, S., Fischer, M. O., Babatasi, G., Morello, R., & Du Cheyron, D. (2021). Extracorporeal Cardiopulmonary Resuscitation and Survival After Refractory Cardiac Arrest: Is ECPR Beneficial?. ASAIO journal (American Society for Artificial Internal Organs : 1992), 67(11), 1232-1239. https://doi.org/10.1097/MAT.0000000000001391
Daubin, Cedric, et al. "Extracorporeal Cardiopulmonary Resuscitation and Survival After Refractory Cardiac Arrest: Is ECPR Beneficial?." ASAIO journal (American Society for Artificial Internal Organs : 1992) vol. 67,11 (2021): 1232-1239. doi: https://doi.org/10.1097/MAT.0000000000001391
Daubin C, Brunet J, Huet J, Valette X, Charbonnier C, Sabatier R, Joret A, Dupeyrat J, Saplacan V, Courtois S, Goursaud S, Fischer MO, Babatasi G, Morello R, Du Cheyron D. Extracorporeal Cardiopulmonary Resuscitation and Survival After Refractory Cardiac Arrest: Is ECPR Beneficial?. ASAIO J. 2021 Nov 01;67(11):1232-1239. doi: 10.1097/MAT.0000000000001391. PMID: 34734925.
Copy Download .nbib Format: NLM
CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM.

Cancers

Belthier G, Homayed Z, Grillet F, Duperray C, Vendrell J, Krol I, Bravo S, Boyer JC, Villeronce O, Vitre-Boubaker J, Heaug-Wane D, Macari-Fine F, Smith J, Merlot M, Lossaint G, Mazard T, Portales F, Solassol J, Ychou M, Aceto N, Mamessier E, Bertucci F, Pascussi JM, Samalin E, Hollande F, Pannequin J.
PMID: 34638450
Cancers (Basel). 2021 Oct 02;13(19). doi: 10.3390/cancers13194966.

Circulating tumor cells (CTCs) are promising diagnostic and prognostic tools for clinical use. In several cancers, including colorectal and breast, the CTC load has been associated with a therapeutic response as well as progression-free and overall survival. However, counting...

Cite
Belthier G, Homayed Z, Grillet F, et al. CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM. Cancers (Basel). 2021;13(19)doi: 10.3390/cancers13194966.
Belthier, G., Homayed, Z., Grillet, F., Duperray, C., Vendrell, J., Krol, I., Bravo, S., Boyer, J. C., Villeronce, O., Vitre-Boubaker, J., Heaug-Wane, D., Macari-Fine, F., Smith, J., Merlot, M., Lossaint, G., Mazard, T., Portales, F., Solassol, J., Ychou, M., Aceto, N., Mamessier, E., Bertucci, F., Pascussi, J. M., Samalin, E., Hollande, F., & Pannequin, J. (2021). CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM. Cancers, 13(19), . https://doi.org/10.3390/cancers13194966
Belthier, Guillaume, et al. "CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM." Cancers vol. 13,19 (2021). doi: https://doi.org/10.3390/cancers13194966
Belthier G, Homayed Z, Grillet F, Duperray C, Vendrell J, Krol I, Bravo S, Boyer JC, Villeronce O, Vitre-Boubaker J, Heaug-Wane D, Macari-Fine F, Smith J, Merlot M, Lossaint G, Mazard T, Portales F, Solassol J, Ychou M, Aceto N, Mamessier E, Bertucci F, Pascussi JM, Samalin E, Hollande F, Pannequin J. CD44v6 Defines a New Population of Circulating Tumor Cells Not Expressing EpCAM. Cancers (Basel). 2021 Oct 02;13(19). doi: 10.3390/cancers13194966. PMID: 34638450; PMCID: PMC8508506.
Copy Download .nbib Format: NLM
Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study.

International journal of organ transplantation medicine

Morvan A, Gazon M, Duperret S, Schmitt Z, Pradat P, Mohkam K, Aubrun F.
PMID: 33335697
Int J Organ Transplant Med. 2020;11(4):166-175.

BACKGROUND: Although liver transplantation (LT) improves survival in cirrhotic patients with hepatopulmonary syndrome (HPS), few data exist concerning post-operative complications in these patients.OBJECTIVE: To compare complications after LT between patients with and without HPS.METHODS: In a case-control study, we...

Cite
Morvan A, Gazon M, Duperret S, et al. Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study. Int J Organ Transplant Med. 2020;11(4):166-175
Morvan, A., Gazon, M., Duperret, S., Schmitt, Z., Pradat, P., Mohkam, K., & Aubrun, F. (2020). Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study. International journal of organ transplantation medicine, 11(4), 166-175.
Morvan, A, et al. "Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study." International journal of organ transplantation medicine vol. 11,4 (2020): 166-175.
Morvan A, Gazon M, Duperret S, Schmitt Z, Pradat P, Mohkam K, Aubrun F. Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study. Int J Organ Transplant Med. 2020;11(4):166-175. PMID: 33335697; PMCID: PMC7726840.
Copy Download .nbib Format: NLM
Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial.

Blood purification

Wallon G, Guth C, Guichon C, Thevenon S, Gazon M, Viale JP, Schoeffler M, Duperret S, Aubrun F.
PMID: 34139706
Blood Purif. 2021 Jun 17;1-8. doi: 10.1159/000515825. Epub 2021 Jun 17.

INTRODUCTION: Liver failure is associated with hepatic and extrahepatic organ failure leading to a high short-term mortality rate. Extracorporeal albumin dialysis (ECAD) aims to reduce albumin-bound toxins accumulated during liver failure. ECAD detoxifies blood using albumin dialysis through an...

Cite
Wallon G, Guth C, Guichon C, et al. Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial. Blood Purif. 2021;1-8doi: 10.1159/000515825.
Wallon, G., Guth, C., Guichon, C., Thevenon, S., Gazon, M., Viale, J. P., Schoeffler, M., Duperret, S., & Aubrun, F. (2021). Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial. Blood purification, 1-8. https://doi.org/10.1159/000515825
Wallon, Grégoire, et al. "Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial." Blood purification vol. (2021): 1-8. doi: https://doi.org/10.1159/000515825
Wallon G, Guth C, Guichon C, Thevenon S, Gazon M, Viale JP, Schoeffler M, Duperret S, Aubrun F. Extracorporeal Albumin Dialysis in Liver Failure with MARS and SPAD: A Randomized Crossover Trial. Blood Purif. 2021 Jun 17;1-8. doi: 10.1159/000515825. Epub 2021 Jun 17. PMID: 34139706.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 34 entries